Rhode Island Hospital landed a five-year, $11.1 million grant from the National Institutes of Health to develop stem-cell-based treatments for lung and bone marrow diseases.
The grant, part of the NIH’s Centers of Biomedical Research Excellence program, will help fund RHI’s research on stem cell biology, aimed at identifying new approaches to tissue reconstruction in lung and marrow diseases. One of its main objectives is to move from basic stem cell studies to clinical trials.
The NIH also doled out $9.3 million to Clemson University for its research on tissue restoration to relieve end-stage organ failure and tissue loss.
The COBRE program aims to boost multidisciplinary centers that concentrate on one core area of research, part of the NIH’s Institutional Development Award program for states that historically haven’t received much NIH funding.